The Physician’s Satisfaction of the Quality of Endoscopy

Clinical trial of comparing the physician’s satisfaction of adequacy of sedation for endoscopy in two groups of patients whose type of sedation will be chosen by the doctor or by the patient

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201606062499N4

Enrollment

140

Registered

2016-11-30

Start date

2015-05-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Diseases of upper digestive system which need endoscopy. Condition 2: Diseases of upper digestive system which need endoscopy. Condition 3: Diseases of upper digestive system which need endoscopy. Oesophagitis Gastric ulcer Barrett oesophagus

Interventions

Intervention 1: Intervention group: The type of sedation (including intravenous Midazolam 1.5 milligram, intravenous Pethidine 12.5 milligram or general anesthesia) will be chosen by the patient afte

Treatment - Drugs

Intervention group: The type of sedation (including intravenous Midazolam 1.5 milligram, intravenous Pethidine 12.5 milligram or general anesthesia) will be chosen by the patient after being educate

Control group 1: In this group, Intravenous Midazolam 1.5 milligram will be injected to the patient before performing endoscopy. The dose and/ or type of sedative may change during endoscopy accordi

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: the need for diagnostic upper gastrointestinal endoscopy Exclusion criteria: age below 18 or above 80 years; severe cardiopulmonary, renal or liver failure

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Physician's satisfaction of the adequacy of sedation for performing endoscopy. Timepoint: Immediately after completing the endoscopy. Method of measurement: questionnaire.	—

Secondary

Measure	Time frame
Quality of endoscopy. Timepoint: during and 20 ??????? after the endoscopy. Method of measurement: questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHafez Fakheri

Mazandaran University of Medical Sciences

hafezfakheri@gmail.com+1 133361700

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026